Gut microbiota remodeling and functional shifts in association with host PPAR signaling during Lianli Decoction treatment of ulcerative colitis

Objectives This study aimed to investigate the multi-level associations among Lianli Decoction (LLD) treatment, the taxonomic and functional remodeling of the gut microbiota, alterations in fecal metabolites, and host peroxisome proliferator-activated receptor (PPAR) signaling in a dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) model. Methods The chemical constituents of LLD were identified, and molecular docking was conducted accordingly. Male C57BL/6J mice were randomized into blank, model, 5-aminosalicylic acid (5-ASA), and low/medium/high-dose LLD (LLD-L/M/H) groups. Disease severity was evaluated using the disease activity index (DAI), histopathological scoring, and colonic cytokine levels (IL-6, TNF-α). Fecal samples from four mice per group were subjected to 16S rRNA gene sequencing coupled with PICRUSt2 functional prediction and untargeted LC-MS metabolomics. Host molecular responses were assessed by Western blotting (PPARα, PPARδ, PPARγ, CPT1A), quantitative PCR ( CPT1A, ACOX1 ), immunofluorescence (CD68+/CD206+), and fatty acid β-oxidation assays. Results LLD-M and LLD-H were associated with reduced DAI scores, attenuated histopathological damage, and lower colonic IL-6 and TNF-α. At the taxonomic level, LLD-M was associated with a shift in overall community composition, an increased Firmicutes/Bacteroidota ratio, and enrichment of Alloprevotella and Parabacteroides . PICRUSt2 analysis indicated a higher predicted abundance, in the LLD-M group, of bacterial KEGG orthologs mapped to the PPAR-associated pathway. Molecular docking predicted favorable binding of berberine within the ligand-binding domains of PPARα and PPARγ. Metabolomics identified increased fecal levels of palmatine and 5-methoxynoracronycine, which were negatively correlated with inflammatory cytokines. Consistently, LLD-M was also associated with higher PPARα, PPARγ and CPT1A protein expression in the colon, an accelerated rate of fatty acid β-oxidation, and increased proportions of CD68 + CD206 + M2 macrophages. The predicted abundance of bacterial KEGG orthologs mapped to the PPAR-associated pathway was positively correlated with host PPAR protein expression. Conclusion LLD-M was associated with a shift in the predicted functional potential of the gut microbiota toward genes mapped to the PPAR-associated KEGG pathway, accompanied by increased host PPAR expression and M2 macrophage markers. This integrated analysis provides a multi-omics association framework for the metabolic crosstalk between bacteria and the host in UC during traditional Chinese medicine intervention; the causal direction of these associations remains to be established.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2026-11-17
DOI
https://doi.org/10.3389/fmicb.2026.1998528
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gut microbiota remodeling and functional shifts in association with host PPAR signaling during Lianli Decoction treatment of ulcerative colitis

Xinyu Yao, Leilei Liu, Yike Sun, Guangqin Zhu et al.
5 links
Frontiers in Microbiology
Gut microbiota and health
article

Gut microbiota remodeling and functional shifts in association with host PPAR signaling during Lianli Decoction treatment of ulcerative colitis

Xinyu Yao, Leilei Liu, Yike Sun, Guangqin Zhu, Jing Li, Jiping Zhang, Shuran Ma, Jinrong Zhang
article en

Abstract

Objectives This study aimed to investigate the multi-level associations among Lianli Decoction (LLD) treatment, the taxonomic and functional remodeling of the gut microbiota, alterations in fecal metabolites, and host peroxisome proliferator-activated receptor (PPAR) signaling in a dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) model. Methods The chemical constituents of LLD were identified, and molecular docking was conducted accordingly. Male C57BL/6J mice were randomized into blank, model, 5-aminosalicylic acid (5-ASA), and low/medium/high-dose LLD (LLD-L/M/H) groups. Disease severity was evaluated using the disease activity index (DAI), histopathological scoring, and colonic cytokine levels (IL-6, TNF-α). Fecal samples from four mice per group were subjected to 16S rRNA gene sequencing coupled with PICRUSt2 functional prediction and untargeted LC-MS metabolomics. Host molecular responses were assessed by Western blotting (PPARα, PPARδ, PPARγ, CPT1A), quantitative PCR ( CPT1A, ACOX1 ), immunofluorescence (CD68+/CD206+), and fatty acid β-oxidation assays. Results LLD-M and LLD-H were associated with reduced DAI scores, attenuated histopathological damage, and lower colonic IL-6 and TNF-α. At the taxonomic level, LLD-M was associated with a shift in overall community composition, an increased Firmicutes/Bacteroidota ratio, and enrichment of Alloprevotella and Parabacteroides . PICRUSt2 analysis indicated a higher predicted abundance, in the LLD-M group, of bacterial KEGG orthologs mapped to the PPAR-associated pathway. Molecular docking predicted favorable binding of berberine within the ligand-binding domains of PPARα and PPARγ. Metabolomics identified increased fecal levels of palmatine and 5-methoxynoracronycine, which were negatively correlated with inflammatory cytokines. Consistently, LLD-M was also associated with higher PPARα, PPARγ and CPT1A protein expression in the colon, an accelerated rate of fatty acid β-oxidation, and increased proportions of CD68 + CD206 + M2 macrophages. The predicted abundance of bacterial KEGG orthologs mapped to the PPAR-associated pathway was positively correlated with host PPAR protein expression. Conclusion LLD-M was associated with a shift in the predicted functional potential of the gut microbiota toward genes mapped to the PPAR-associated KEGG pathway, accompanied by increased host PPAR expression and M2 macrophage markers. This integrated analysis provides a multi-omics association framework for the metabolic crosstalk between bacteria and the host in UC during traditional Chinese medicine intervention; the causal direction of these associations remains to be established.

Frontiers in MicrobiologyVol. 17
Beijing University of Chinese Medicine (CN)
National Natural Science Foundation of China, Beijing University of Chinese Medicine, Servier
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon